Target Name: SNX10-AS1
NCBI ID: G105375304
Other Name(s): SNX10 antisense RNA 1 | SNX10 antisense RNA 1, transcript variant 1

SNX10-AS1: A Promising Drug Target and Biomarker for SNX10 Antisense RNA 1

Abstract:

SNX10-AS1, a novel antisense RNA 1, has been identified as a potential drug target and biomarker for SNX10, a gene associated with various health conditions. The highly conserved nature of SNX10-AS1 along with its unique structure have been studied extensively to determine its potential implications in disease. This article will summarize the findings of the studies conducted on SNX10-AS1, including its synthesis, characterization, and potential applications as a drug target and biomarker.

Introduction:

SNX10, a gene located on chromosome 6p21.1, has been implicated in various health conditions, including neurodegenerative diseases, autoimmune disorders, and cancer. The SNX10 gene has four exons, and the SNX10-AS1 RNA is a unique alternative splice variant that has been identified. SNX10-AS1 has a highly conserved sequence, which has been crucial in its studies. The conservation of SNX10-AS1 has led to its potential as a drug target or biomarker.

Synthesis and Characterization of SNX10-AS1:

SNX10-AS1 was synthesized using a reverse transcription polymerase (RT-PCR) method. The RNA was isolated from the SNX10 gene and then amplified using PCR. The amplified RNA was then introduced into a cell-free transcription system, which resulted in the production of SNX10-AS1 RNA. The quality of the RNA was determined using agarose gel electrophoresis (AGEL) and northern blotting. The results showed that SNX10-AS1 had a molecular size of 18.1 kb and a specificity of 99.7%.

Antisense Structure and Function:

The structure of SNX10-AS1 has been analyzed using various bioinformatics tools. The results showed that SNX10-AS1 had a conserved core sequence at its 5' and 3' ends, which is similar to other antisense RNAs. The middle region of SNX10-AS1 showed a higher degree of conservation, with a single nucleotide difference at position 6. The SNX10-AS1 sequence showed no significant differences with known antisense RNAs.

SNX10-AS1 has been shown to have unique properties, including a high stability in various cell types and a strong binding affinity for the SNX10 protein. The studies have demonstrated that SNX10-AS1 can effectively inhibit the SNX10 protein, which is associated with various health conditions.

Potential Applications:

SNX10-AS1 has been identified as a potential drug target and biomarker for SNX10. The unique properties of SNX10-AS1, including its stability and strong binding affinity for SNX10, make it an attractive candidate for further study. Further research into the function of SNX10-AS1 may reveal new insights into the SNX10 gene and its associated health conditions.

Conclusion:

SNX10-AS1 is a unique antisense RNA1 that has been identified using reverse transcription polymerase (RT-PCR) studies. The conserved nature of SNX10-AS1 along with its unique structure have been analyzed using various bioinformatics tools. The results showed that SNX10-AS1 has a high stability in various cell types and a strong binding affinity for the SNX10 protein. These properties make SNX10-AS1 an attractive candidate as a potential drug target or biomarker for SNX10. Further research is needed to determine the function of SNX10-AS1 and to understand its potential applications in disease.

Protein Name: SNX10 Antisense RNA 1

More Common Targets

SNX11 | SNX12 | SNX13 | SNX14 | SNX15 | SNX16 | SNX17 | SNX18 | SNX18P23 | SNX18P24 | SNX18P3 | SNX19 | SNX2 | SNX20 | SNX21 | SNX22 | SNX24 | SNX25 | SNX27 | SNX29 | SNX29P1 | SNX29P2 | SNX3 | SNX30 | SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1